Company overview
Europa Biosite is a leading pan-European distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances, offering access to over ten million products including antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens. Headquartered in Stockholm, the company operates in 17 countries across Europe and North America, supporting over 60,000 academic and biopharma researchers. It comprises six key distribution companies and focuses on locally-tailored commercial solutions for suppliers.
Europa Biosite is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include europa biosite, life science distributor, research reagents, antibodies supplier, biopharma reagents.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.europabiosite.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- europa biosite, life science distributor, research reagents, antibodies supplier, biopharma reagents
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What products does Europa Biosite distribute?
- Europa Biosite distributes over ten million RUO life science products, including antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens from science-led suppliers.
- In which geographies does Europa Biosite operate?
- Europa Biosite operates in 17 countries across Europe and North America, with representation through subsidiaries like Biomol (Germany), Cambridge Bioscience (UK/Ireland), and others.
- What is the scale and focus of Europa Biosite's business?
- With over 180 employees, Europa Biosite supports more than 60,000 researchers in academia and biopharma, emphasizing high-quality reagents for healthcare R&D and life science distribution standards.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
